Category : Search result: pharmaceutical barrier materials


Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Grey Bruce drug disposal nets meds for hockey tickets

Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.

Dipharma's Novel Method Detects Nitrosamine Risks

Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.

Windsor mayor promises smaller blue bin options

Windsor Mayor Drew Dilkens announces a solution for residents struggling with new oversized recycling bins. A pathway to smaller bins is coming. Read the latest on Ontario's new recycling program.

Novo Nordisk Alzheimer's Drug Trials Fail

Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.

Eli Lilly Reaches $1 Trillion Valuation Milestone

Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.

Denmark compensates for Novo Nordisk vision loss

Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.

$3.2B EV Battery Plant Coming to St. Thomas, Ontario

Ontario secures a massive $3.2 billion Vianode investment for a new EV battery materials plant in St. Thomas, boosting Canada's electric vehicle supply chain. Learn more about this economic win.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

9 killed in Kashmir police station explosion

Tragic explosion at Indian-controlled Kashmir police station leaves 9 dead and 32 injured after confiscated explosives detonated. Latest details on the investigation.

Barbados Launches US$200M Life Sciences Hub

Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.

GM urges suppliers to move supply chains from China

General Motors executives are pressuring suppliers to find alternatives to Chinese raw materials and components, signaling a major shift in automotive supply chains. Learn about this strategic move.

Create a Home Sanctuary with Wellness Design

Interior designer Reisa Pollard shares how to transform your home into a wellness sanctuary. Discover tips for better sleep, decompression zones, and natural materials.

Page 2 of 3